Medicenna Therapeutics Corporation.

MDNAF

Financials

20-FAnnual report (foreign)06/27/2320-FAnnual report (foreign)06/22/2240-FAnnual report (Canadian)05/28/21

Disclosures

6-KForeign issuer report05/13/246-KForeign issuer report04/30/246-KForeign issuer report04/26/246-KForeign issuer report04/25/246-KForeign issuer report04/10/24

Prospectuses and Registrations

POS AMPost-effective amendment05/10/24F-10POSProspectus / registration04/16/24F-3/AShelf registration (foreign, amended)04/16/24S-8 POSPost-effective amendment (S-8)04/16/24F-3Shelf registration (foreign)02/17/23

Proxies

No matching filings.

Ownership

SC 13GBeneficial ownership05/10/24SC 13G/ABeneficial ownership (amended)02/21/24SC 13G/ABeneficial ownership (amended)02/07/24SC 13G/ABeneficial ownership (amended)02/15/23SC 13G/ABeneficial ownership (amended)02/14/23

Other

DD07/06/2615-12GCertification of termination of registration05/14/24DD05/14/24EFFECTRequest for effectiveness05/13/24AWWithdrawal request04/22/24